Bio-Rad’s Gene Pulser MXcell Electroporation System
Guides Are Now Available
HERCULES,
Calif., January 16, 2008 – Bio-Rad
Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and
distributor of life science research and clinical diagnostic products, today announced
two new product guides for its Gene Pulser MXcell™ electroporation
system. The first product guide (bulletin 5640) is designed to assist
scientists using the pre-set protocols in order to quickly optimize
electroporation conditions. The bulletin contains detailed information for the MXcell’s
preset protocols as well as information on a Decision Tree that aids in
protocol selection. The second is an ordering guide (Bulletin 5598) that
itemizes systems features, specifications and other information needed to order
the MXcell system. The guides may be downloaded at www.bio-rad.com.
About
the Gene Pulser MXcell Electroporation System
The Gene Pulser MXcell electroporation system is fully
programmable and can deliver up to 24 different electroporation protocols in a
single 96-well plate in two minutes or less. Unlike other instruments in which
scientists may not be able to fine tune their system to get higher
efficiencies, the MXcell system paired with the Gene Pulser electroporation
buffer provides researchers a way to quickly optimize electroporation
conditions to maximize the use of their cells and samples. The system can also
be used as a rapid screening tool for the delivery of siRNA into any type of
mammalian cell line.
The
MXcell system features disposable 12-, 24- and
96-well plates offering options for high-throughput,
replicated optimization, as well as multiple
lab-scale transfections in a single plate. The software has gradient
programming and pre-set optimization protocols for rapid plate set-up.
Target customers for the system are
researchers at all levels in molecular biology laboratories in academia, core
laboratories, and biotechnology, and pharmaceutical companies. At half the list
price of other systems, the MXcell system enables scientists to conduct research
on more medically relevant cells including stem cells.
About
Electroporation
Electroporation is a
valuable tool for nucleic acid delivery because it can be used for a wide
variety of cell types. Along with a general movement in the scientific
community to use more medically relevant cells, new tools for electroporation
have become necessary as more scientists optimize delivery of siRNA, plasmids, or other
molecules into mammalian cells, in
particular, primary cells and those cells that are difficult to transfect.
About Bio-Rad
Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb) has remained at the center of
scientific discovery for more than 50 years manufacturing and distributing a
broad range of products for the life science research and clinical diagnostic
markets. The company is renowned worldwide among hospitals, universities, major
research institutions, as well as biotechnology and pharmaceutical companies
for its commitment to quality and customer service. Founded in 1952, Bio-Rad is
headquartered in Hercules, California, and serves more than 85,000 research and
industry customers worldwide through its global network of operations. The
company employs approximately 6,300 people
globally and had revenues of nearly $1.3 billion in 2006. For more information,
visit www.bio-rad.com.
This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, “believe,” “expect,” “may,” “will,” “intend,” “estimate,” “continue,” or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company's risks and uncertainties, please refer to the “Risk Factors” in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, as updated by subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc. disclaims any obligation to update these forward-looking statements.
NOTE TO THE EDITOR:
For an html link to this news please
visit the following URL: http://www.alchymiacomm.com/NewsReleasesPhotography.htm
Sales information may be obtained by
calling a Bio-Rad sales office at 1-800-424-6723. Please do not use editor contact or corporate
telephone numbers.
Information in this release applies
specifically to products available in the United States. Product availability
and specifications may vary in non‑U.S. markets.
If you choose to review this item, your readers
will receive the quickest response to their inquiries by e‑mailing them
to lsg.orders.us@bio-rad.com
or by calling 1-800-424-6723.
For more
information, please contact:
Jamie Wibbenmeyer Doug
Forsyth
Bio-Rad Laboratories, Inc. Alchymia Communications® LLC
510-724-4770 541-482-8744